| Urinary tract infection

Zemdri vs Avycaz

Side-by-side clinical, coverage, and cost comparison for urinary tract infection.
Deep comparison between: Zemdri (Plazomicin) vs Avycaz with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsAvycaz has a higher rate of injection site reactions vs Zemdri (Plazomicin) based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Avycaz but not Zemdri (Plazomicin), including UnitedHealthcare
Sign up to reveal the full AI analysis
Zemdri (Plazomicin)
Avycaz
At A Glance
IV infusion
Every 24 hours
Aminoglycoside
IV infusion
Every 8 hours
Cephalosporin/beta-lactamase inhibitor
Indications
  • Urinary tract infection
  • Urinary Tract Infection
  • Pneumonia, Bacterial
Dosing
Urinary tract infection 15 mg/kg every 24 hours by IV infusion over 30 minutes for 4 to 7 days in adults with CLcr >=90 mL/min; dose reduced to 10 mg/kg every 24 hours (CLcr 30 to <90 mL/min) or 10 mg/kg every 48 hours (CLcr 15 to <30 mL/min).
Complicated Intra-abdominal Infections, Urinary Tract Infection, Pneumonia, Bacterial 2.5 grams (ceftazidime 2 grams and avibactam 0.5 grams) IV every 8 hours infused over 2 hours in adults with CrCl > 50 mL/min; cIAI requires concurrent metronidazole; dosage adjustment required for CrCl <=50 mL/min; duration 5-14 days (cIAI) or 7-14 days (cUTI, HABP/VABP).
Contraindications
  • Known hypersensitivity to any aminoglycoside
  • Known serious hypersensitivity to ceftazidime, avibactam, avibactam-containing products, or other members of the cephalosporin class
Adverse Reactions
Most common (>=1%) Decreased renal function, diarrhea, hypertension, headache, nausea, vomiting, hypotension
Serious Nephrotoxicity, ototoxicity, neuromuscular blockade, fetal harm, hypersensitivity reactions, Clostridium difficile-associated diarrhea
Most common (>=5%) Diarrhea, nausea, vomiting (cIAI); diarrhea, vomiting (HABP/VABP); nausea, diarrhea (cUTI)
Serious Hypersensitivity reactions, Clostridioides difficile-associated diarrhea, central nervous system reactions (including seizures, encephalopathy), increased mortality in patients with moderate renal impairment (CrCl 30-50 mL/min) if underdosed
Postmarketing Colitis, toxic nephropathy, hepatic dysfunction including cholestasis, hemorrhage, pancytopenia, aplastic anemia, prolonged prothrombin time, false-positive urinary glucose, acute myocardial ischemia
Pharmacology
Plazomicin is an aminoglycoside antibacterial that binds to the bacterial 30S ribosomal subunit, inhibiting protein synthesis with concentration-dependent bactericidal activity against Enterobacteriaceae.
Ceftazidime is a cephalosporin that exerts bactericidal activity by binding penicillin-binding proteins of susceptible gram-negative bacteria; avibactam is a non-beta-lactam beta-lactamase inhibitor that inactivates certain beta-lactamases (including KPCs, ESBLs, and AmpC enzymes) that would otherwise degrade ceftazidime, thereby restoring ceftazidime activity against resistant organisms.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Zemdri (Plazomicin)
  • Covered on 5 commercial plans
  • PA (5/12) · Step Therapy (5/12) · Qty limit (0/12)
View full coverage details ›
Avycaz
  • Covered on 5 commercial plans
  • PA (6/12) · Step Therapy (6/12) · Qty limit (0/12)
View full coverage details ›
UnitedHealthcare
Zemdri (Plazomicin)
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Avycaz
  • Covered on 4 commercial plans
  • PA (1/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Humana
Zemdri (Plazomicin)
  • Covered on 0 commercial plans
  • PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
View full coverage details ›
Avycaz
  • Covered on 0 commercial plans
  • PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Zemdri (Plazomicin).
Cost estimate not availableHealthWell: Cystic Fibrosis Treatments
Commercial or private insurance
Medicare, Medicaid, VA, TRICARE
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
Zemdri (Plazomicin)View full Zemdri (Plazomicin) profile
AvycazView full Avycaz profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.